ACALDO CAPSULE

* Is well-tolerated, with a consistent safety profile. Phlebology 2016 May: 31(4):264-74

* Protects human varicose veins against oxidative stress in vitro at levels that correspond to therapeutic concentrations. Phlebology, 2011 Dec;26(8):332-7.

* Decreases platelet aggregation (clotting-adhesion of platelets) & reduces the serum viscosity, which improves blood circulation & blood supply to tissues and organs.

* This medicine is also an antioxidant (prevents damage from free radicals).

* It provides an efficient, fast, and safe symptomatic relief from acute symptoms of hemorrhoidal disease. Dis Colon Rectum. 2001 Oct;44(10):1489-95

* In Diabetic Retinopathy and in CVI, it exerts its therapeutic effect in micro-circulatory disorders by reducing capillary permeability, inhibiting platelet aggregation and thrombus formation, lowering blood hyper-viscosity, and increasing red cell flexibility. It also improves lymphatic drainage, which contributes to its anti-edematous effect. Current Therapeutic Research 1995; 56(4) 346-56.

* It is an effective adjuvant therapy, with an absence of significant side-effects, in patients with venous ulcers and stasis dermatitis. It significantly improves the clinical parameters of pain, itching, tiredness, heaviness, and leg swelling.

It also significantly decreases the ulcer size. Int J Dermatol. 2003 Feb;42(2):147-52.

Indications:

**Hemorrhoids

**Varicose Veins and Edema

**Other Microvascular Disorders

**Peripheral Circulatory Disorders

**Atherosclerosis

**Diabetic Retinopathy

** Phlebitis & Thrombophlebitis

** Chronic Venous Insufficiency (CVI)